Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Comprehensive & Immersive Soft Tissue Pathology Course
Event Details
Offered both online and in person, this four-day course is designed specifically for pathologists in academic, community, and private practice settings, as well as trainees. Set within one of the nation’s busiest soft tissue and sarcoma consultation services, it delivers a one-of-a-kind, high-yield experience built around real-world cases and refreshed annually to maximize diagnostic value.
Participants will digitally preview a broad spectrum of soft tissue cases—ranging from benign lesions and reactive mimics to high-grade sarcomas—followed by highly interactive, case-based discussions with world-renowned faculty. Interspersed lectures focusing on a practical approach to common diagnostic scenarios will complement these case sessions.
During this course, attendees will have developed practical skills and diagnostic tools to effectively work up and triage mesenchymal lesions encountered in everyday practice.
Featuring all-new course content, this year’s faculty includes Dr. Karen Fritchie, Dr. Brian Rubin, Dr. John Goldblum, Dr. Steven Billings, and Dr. Josephine Dermawan.
Participants may attend virtually to earn 16.5 CME credits or join in person for an expanded experience offering 27.75 CME credits and enhanced interactive discussion.